
    
      At discharge, high-risk HF patients are selected and randomized in two groups:

        -  Control group: usual disease management according to guidelines and including first
           medical consultation and biological test within the 4-week time following discharge.

        -  Active group: consultations with HF specialist including biological test at weeks 1, 2
           and 4 are planned in addition to usual management.
    
  